Global contract packaging organization (CPO) Tjoapack has invested in its blistering capacity to extend its late-stage customisation and postponement offering.

The company added a new line that will be equipped with late-stage customisation printing capabilities.

The new line, at the company?s plant in Etten-Leur, Netherlands, is anticipated to start operations by the end of the third quarter of 2018

It will take the company’s total number of blistering lines to eight.

Tjoapack said it is committed to make sure that its customers continue to receive the efficient and flexible service that they’re used to, as it looks for ways to further enhance its operations in order to better cater for their projects.

“We have a strategic growth plan in place and increasing our blistering capacity will allow us to cater for increasing demand from both current and new customers,” the company said.

Tjoapack expects the investment to expand its current postponement printing offering and allow the company’s CPO to offer drop-on-demand digital printing for blisters.

The company noted that late-stage customization, or postponement printing, is presenting some interesting benefits for the pharmaceutical supply chain.

The process of only making packaging market-specific is expected to benefit with respect to waste reduction from repackaging, overall costs and time to market.

Tjoapack said it is exploring this type of packaging with some of its customers already and as more complex molecules continue to enter the drug pipeline, demand for last-minute packaging is likely to increase.

The latest investment will enable the company to futureproof our lines for projected demands.”

Tjoapack is a West-European contract packer for the pharmaceutical, biotec and medtec industries.

The CPO is engaged in providing primary packaging for solid dosage forms, secondary packaging and unit dose packaging. The firm has a total of 19 packaging lines for blisters, wallets and bottles.

The firm is capable of packages around 26 million packs of pharmaceutical products annually.